Israel
· Delayed Price · Currency is ILS · Price in ILAOPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of ILS 4.19 billion. The enterprise value is 4.60 billion.
| Market Cap | 4.19B |
| Enterprise Value | 4.60B |
Important Dates
The last earnings date was Thursday, November 7, 2024.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.19% |
| Shares Change (QoQ) | +43.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 266.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.26 |
| EV / Sales | 1.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.19 |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.97 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.56 |
| Interest Coverage | -8.44 |
Financial Efficiency
Return on equity (ROE) is -9.39% and return on invested capital (ROIC) is -10.55%.
| Return on Equity (ROE) | -9.39% |
| Return on Assets (ROA) | -8.97% |
| Return on Capital (ROIC) | -10.55% |
| Revenue Per Employee | 672,905 |
| Profits Per Employee | -126,496 |
| Employee Count | 3,930 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 9.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.90% in the last 52 weeks. The beta is 1.63, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | +18.90% |
| 50-Day Moving Average | 569.21 |
| 200-Day Moving Average | 495.57 |
| Relative Strength Index (RSI) | 61.01 |
| Average Volume (20 Days) | 1,570,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 26.98 |
Income Statement
In the last 12 months, OPKO Health had revenue of ILS 2.64 billion and -497.13 million in losses. Loss per share was -0.72.
| Revenue | 2.64B |
| Gross Profit | 313.65M |
| Operating Income | -1.15B |
| Pretax Income | -438.10M |
| Net Income | -497.13M |
| EBITDA | -778.25M |
| EBIT | -1.15B |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 1.49 billion in cash and 1.90 billion in debt, giving a net cash position of -417.22 million.
| Cash & Cash Equivalents | 1.49B |
| Total Debt | 1.90B |
| Net Cash | -417.22M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.22B |
| Book Value Per Share | 7.64 |
| Working Capital | 1.55B |
Cash Flow
In the last 12 months, operating cash flow was -659.35 million and capital expenditures -84.08 million, giving a free cash flow of -743.43 million.
| Operating Cash Flow | -659.35M |
| Capital Expenditures | -84.08M |
| Free Cash Flow | -743.43M |
| FCF Per Share | n/a |
Margins
Gross margin is 11.86%, with operating and profit margins of -43.50% and -18.80%.
| Gross Margin | 11.86% |
| Operating Margin | -43.50% |
| Pretax Margin | -16.57% |
| Profit Margin | -18.80% |
| EBITDA Margin | -29.43% |
| EBIT Margin | -43.50% |
| FCF Margin | -28.11% |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.19% |
| Shareholder Yield | 5.19% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.54. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.54 |
| Piotroski F-Score | n/a |